Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008
Date:5/29/2008

Caraco has the exclusive right to market any products offered by Sun Pharma and accepted by Caraco under these agreements."

Mr. Movens added, "Pantoprazole, which was launched during the fourth quarter, and oxcarbazepine, which was launched during the third quarter, were the most recent significant drivers of our sales. Excluding oxcarbazepine and pantoprazole sales, our base business continued to experience growth throughout Fiscal 2008. We had gained seventeen new product approvals throughout the year of both Caraco and Sun Pharma products to complement our portfolio of existing products."

"Our strategy remains to grow the business appropriately by utilizing all of our diverse paths of development. The weight of distributed product sales has significantly increased during Fiscal 2008 due to recent launches, which will most likely continue on a short-term basis. Overall, we are pleased with the direction of the Company and our continued focus on executing Caraco's business plan is a major factor in the Company's success."

Fourth Quarter and Fiscal 2008 Results

During the fourth quarter and Fiscal 2008, net sales rose to a record $191.8 million and $350.4 million, respectively, from $32.7 million and $117.0 million for the corresponding periods of Fiscal 2007. Gross profit during the relevant periods improved to $27.5 million and $84.7 million, as compared to $15.4 million and $57.8 million for the corresponding periods of Fiscal 2007, reflecting an increase of 79% and 47%, respectively. The increase in gross profit was due to higher sales, primarily of distributed products, including new launches of Paragraph IV products, under the agreements with Sun Pharma.

The gross profit margin decreased to 24% in Fiscal 2008 from 49% in Fiscal 2007. The decrease was primarily due to the weight of increased sales of distributed products versus the sales of manufactured products, which had an impact on the overall margins. Net sales for distri
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
4. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
5. Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008
6. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
7. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R)
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... July 06, 2015 , ... Invitation to Cover: , Most ... a large gap between the unmet health priorities in the region and the ... reduce unnecessary or ineffective treatments or procedures. , This milestone conference, sponsored by ...
(Date:7/6/2015)... ... 2015 , ... Understanding the new ICD-10 requirements is crucial ... transition. ADVOCATE, the only 100% radiology, revenue cycle management company in the nation, ... ten tips are timely and relevant guidelines to help radiology practices avoid coding ...
(Date:7/6/2015)... ... 2015 , ... Seedstock today announced Pierre Sleiman, founder and CEO of ... Sustainable Agriculture Conference – “Innovation and the Small Farmer” – to be held Nov. ... California-San Diego, will explore solutions and methodologies that small farmers and entrepreneurs are developing ...
(Date:7/6/2015)... ... , ... In a split second, breaking a bone can cause loss of ... fracture through the bone health screenings conducted by American Bone Health trained Peer Educators ... residents need this information to remain independent and strong for many more years,” according ...
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is ... area patients. Kybella is a non-surgical method to dissolve fat cells and ... moderate to severe fat deposits under the chin, commonly known as a double chin. ...
Breaking Medicine News(10 mins):Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:National Bone Health Screening and Awareness Day 2Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2
... As increasing numbers of childhood cancer patients survive into ... consideration in treatment, say senior cancer and fertility scientists. ... and New Zealand are diagnosed with cancer every year, ... at Melbourne’s Royal Children’s Hospital. ,“About ...
... to a new research from UT Southwester Medical Center, children ... more at risk for strokes later in life. // ... cranial radiation therapy to kill the cancer showed even greater ... which appears in the Nov. 20 issue of the Journal ...
... eggs with red yolk are considered to be more nutritious ... eggs are natural – says a recent investigations. ... investigation that found that the red color found in many ... as Sudan Red I, a toxic industrial colorant, being used ...
... a connection between chronic lung diseases and rheumatoid ... estimates about the strength of this connection // ... criteria for these diseases. Addressing this problem, Mayo ... of Rheumatology Annual Meeting on Nov. 11 confirming ...
... Researchers at the University of Pennsylvania School of Medicine ... leukemia (AML). Several lines of evidence point to a ... creatures that took over the starship Enterprise in the ... fruit flies. ,“Tribbles had never been directly ...
... declines in their memory during and after menopause, a change ... changes they weather during that time. // ,Now, ... hormone therapy might help women retain certain memory functions. In ... Clinical Endocrinology & Metabolism, they report that a group of ...
Cached Medicine News:Health News:Preserving Fertility for Child Cancer Patients 2Health News:Childhood Survivors Of Brain Tumors More At Risk For Strokes Later In Life 2Health News:Childhood Survivors Of Brain Tumors More At Risk For Strokes Later In Life 3Health News:Fear Of Cancer Due To Duck Egg Contamination In China 2Health News:Study Examines Link Between Rheumatoid Arthritis and Chronic Lung Diseases 2Health News:"Tribbles" Protein Implicated in Leukemia 2Health News:Hormone Therapy May Improve the Trip Down Memory Lane 2
(Date:7/6/2015)... PARIS , July 6, 2015 ... inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy ... Japan,s Ministry of Health, ... Confocal Laser Endomicroscopy solution, the AQ-Flex 19 miniprobe. ... Cellvizio AQ -Flex™ 19 miniprobe is comprised of ...
(Date:7/6/2015)... 2015 Research and Markets( ... "Pharmaceutical Packaging Market in North America 2015-2019" report ... in North America to grow ... International regulations regarding safe drug delivery ... in turn fuels adoption of sustainable packaging. Various raw ...
(Date:7/6/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/45v9b3/urinary_slings ) ... Market in the US 2015-2019" report to their ... market in the US to grow at a CAGR ... report covers the present scenario and the growth prospects ... the period 2015-2019. To calculate the market size, the ...
Breaking Medicine Technology:Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 3United States Urinary Slings Market 2015-2019 - Vaginal Slings (TVT, TOT, and Single-incision) & Male Slings (Artificial Urinary Sphincters) 2
... BEVERLY HILLS, Calif., June 27, 2011 OXIS International, ... Paris: OXI) today announced that it has named former ...  The Company,s Board now has four members, including three ... bring an executive of Ken,s caliber to the OXIS ...
... 27, 2011 Columbia Laboratories, Inc. (Nasdaq: CBRX ... today announced that the U.S. Food and Drug Administration (FDA) ... PROCHIEVE ® (progesterone gel) for the reduction of risk ... in the mid-trimester of pregnancy. The acceptance of the NDA ...
Cached Medicine Technology:OXIS International Names Former Wal-Mart Executive Ken Eaton to Board of Directors 2OXIS International Names Former Wal-Mart Executive Ken Eaton to Board of Directors 3Columbia Laboratories' NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA 2Columbia Laboratories' NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA 3Columbia Laboratories' NDA for PROCHIEVE® Vaginal Progesterone Gel Accepted for Filing by FDA 4
ThermalSeal RT (2mil) is Optically Clear for Real Time PCR and easy to apply. Works for all plates....
Sealing tape featuring 3M adhesive technology. Superior optical properties. Low autofluorescense. Some residue will remain if using DMSO. Non-tacky to skin and gloves....
Sealing tape featuring 3M adhesive technology. Repeat piercing with minimal residue. Not recommended for DMSO. Non-tacky to skin and gloves....
Sealing tape, white Rayon, breathable, NS...
Medicine Products: